| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 542,400 | 503,700 | 492,300 | 495,400 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 503,700 | 492,300 | 495,400 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 209,000 | 372,000 | 378,600 | 446,700 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 163,200 | 131,700 | 113,700 | 48,700 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 2,300 | (2,300) | (3,400) | | Earnings Before Interest And Taxes | 175,000 | 134,000 | 111,400 | 45,300 | | Interest Expense | 3,900 | 4,000 | 3,900 | 3,900 | | Income Before Tax | 171,100 | 130,000 | 107,500 | 41,400 | | Income Tax Expense | 25,300 | 19,600 | 16,100 | 19,600 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 145,800 | 110,400 | 91,400 | 21,800 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 145,800 | 110,400 | 91,400 | 21,800 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $145,800 | $110,400 | $91,400 | $21,800 |
|
0.03% Nasdaq 
0.07 (0.27%) 
Income Statement
